| 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 7Y | 10Y | Since launch | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fund | — | — | — | — | — | — | — | — | — | — |
| NIFTY Healthcare TRI | +12.35% | +6.16% | +10.59% | +20.00% | +18.07% | +20.97% | +15.83% | — | — | — |
| Category middle | +7.06% | +0.76% | +8.56% | +4.78% | +4.51% | +14.52% | +13.44% | +17.70% | +15.67% | — |
| Volatility | — |
| Sharpe | — |
| Sortino | — |
| Beta | — |
| Alpha | — |
| Deepest fall | — |
| 1-year periods with a loss | — |
| 5Y SIP XIRR | — |
| Apollo Hospitals Enterprise Limited | 7.89% |
| IPCA Laboratories Limited | 7.49% |
| Cipla Limited | 7.40% |
| Sun Pharmaceutical Industries Limited | 7.32% |
| Gland Pharma Limited | 6.61% |
| Sai Life Sciences Limited | 6.17% |
| Globus Medical Inc | 5.36% |
| Alkem Laboratories Limited | 4.73% |
| Divi's Laboratories Limited | 4.41% |
| Cohance Lifesciences Limited | 3.82% |
| Alembic Pharmaceuticals Limited | 3.09% |
| Thyrocare Technologies Limited | 2.84% |
| Pharmaceuticals & Biotechnology | 66.0% |
| Healthcare Services | 20.8% |
| Healthcare Equipment & Supplies | 9.0% |
| Foreign Security | 1.1% |
| Insurance | 1.0% |
Calculated by Growth Analyser from AMFI NAVs and the fund house's disclosed portfolio. Up to 1 year: total return; longer: CAGR. Research and education only; not investment advice. Mutual fund investments are subject to market risks; read all scheme-related documents carefully. Past performance does not indicate future returns.